(1) Background: Any disturbance in the pharmaceutical supply chain (PSC) can disrupt the supply of medicines and affect the efficiency of health systems. Due to shortages in the global pharma supply chain over the past few years and the complex nature of free trade and its limitations when...

The main goal of this research is to study the impact of uncertainty on export performance, from a resource-based perspective. Despite the ample research on how economies behave during periods of high uncertainty, there is still a poor understanding of how this affects smaller sectors,...

Infolge der Corona-Pandemie verstärkten sich auch in Deutschland die Forderungen nach einer Rückverlagerung pharmazeutischer Produktionen. Als Argument wird eine strategische Abhängigkeit von nicht europäischen Wirkstoff- und Arzneimittelherstellern angeführt. Doch die deutsche...

The purpose of this study is to identify elements that influence the sale of generic pharmaceutical products during their life cycle in order to achieve more comprehensive planning and to prevent a decline stage of the product life cycle (PLC). We used a system dynamic model to identify the...

For nearly 3 years now, Lebanon has been assailed by compounded crises. With the economic instability, the coronavirus pandemic, and the explosion of the Beirut Port on August 4, 2020; the fragile Lebanese healthcare system has found itself at massive risk of a catastrophic public health crisis...

Employee involvement and participation is part of Labor Relations and Human Resource Management. This study is to identify how and to what extent employee involvement and employee participation mechanisms are used in the Greek subsidiaries of multinational companies in the pharmaceutical...

Corporate management is often accused of short-term oriented behaviour related to R&D expenditures. This study analyses the influence of R&D volatility and R&D intensity on the market capitalization of pharmaceutical and medical research companies from Europe, considering the institutional...

The advancement of technology in the biopharmaceutical industry has spearheaded the speed and scale of digitalization in various aspects. New drug development is becoming more complex, costly, and challenging. This paper examines how the pharmaceutical value chain model could integrate with the...

We analyze the association that pharmaceutical innovation had with premature mortality from all diseases in Switzerland during the period 1996-2018, and its association with hospital utilization for all diseases in Switzerland during the period 2002-2019. The analysis is performed by...

Infolge der Corona-Pandemie verstärkten sich auch in Deutschland die Forderungen nach einer Rückverlagerung pharmazeutischer Produktionen. Als Argument wird eine strategische Abhängigkeit von nicht europäischen Wirkstoff- und Arzneimittelherstellern angeführt. Doch die deutsche...

Under Articles 31 and 31bis of the TRIPS Agreement, WTO members may validly sanction the use of a patented invention without the patent owner's authorization by issuing a compulsory license (CL). In the pharmaceuticals space, governments have historically employed compulsory licenses to compel...

Cross-border acquisitions by Indian companies have increased tremendously, especially during the last two decades, and the pharmaceutical industry is one of the top acquiring industries. This study verifies the relationship between cross-border acquisitions and shareholders’ wealth in the...

The management of shop floor behavior plays a critical role for the success of operational improvement programs, which rely on the workers that perform the direct value creation tasks. But what precisely should managers do to influence that behavior constructively? In the corresponding stream of...

The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered (or self-administered) to patients, with the aim to cure them, vaccinate them, or alleviate the symptoms. Pharmaceutical companies may deal in generic or...

We utilize a novel identification strategy to analyze the impact of assets in place on firms' decisions for future projects. We exploit the context in the pharmaceutical industry, where the loss of market exclusivity for a branded drug can be used to separate the impact of cash flows generated...

Purpose: To adjust the inventory supply planning, through digital transformation that allows automation and tracking of demand behavior in real time and with low cost tool. Methodology: The collected database is loaded into an Excel along with the required input variables in each of the...

We study the patent strategy of pharmaceutical firms in reaction to the threat of generic entry. Estimating difference-in-differences saturated with a host of fixed effects, we show that while these firms continue to produce patents after a drug is approved by the US Food and Drug Administration...

Theory shows that ownership stakes between firms can mitigate hold-up costs that wouldotherwise impede interfirm collaboration. We construct a model of the pharmaceutical industrythat predicts hold-up costs are an inverted U-shaped function of the collaborative drug’s likelihoodof approval....

Pharmaceutical patents represent some of the most valuable intellectual property assets in the world: they can be worth billions of dollars if courts uphold their validity and find them infringed. But, if invalidated, generic drug manufacturers can get to market earlier, generating billions of...

This paper analyses the integrated circuit and pharmaceutical GVCs to determine the scope of technical upgrading and value capture achieved by Chinese and Indian contract R&D firms within these GVCs. There are three main findings. First, the two sectors differ significantly in terms of the...

This paper aims to analyze the interfaces between Brazilian Competition Law and the issue of access to medicines, with a special focus on abuse of industrial property rights and related exclusionary and exploitative effects. The paper analyzes the case law of Brazilian Administrative Council for...

The 2019 COVID-19 pandemic led to an economic slowdown worldwide and shook the investment world. Pharmaceutical investments were influenced by the anticipation of COVID-19 vaccine developments. Our study examines the real-time impact of public announcements concerning COVID-19 vaccine...

The purpose of this study is to investigate the mediating role of reflective moral attentiveness in the relationship between financial incentives idiosyncratic deals and unethical pro-organizational behaviors in the pharmaceutical sales sector. In this study, data collected from 310 sales...

Robust protection of competition is particularly important in the field of pharmaceuticals as this may help to improve access to affordable medicines and foster medical innovation. While the Antimonopoly Committee of Ukraine (AMCU) has undertaken certain activities in the pharmaceutical sector...

This paper studies how competition impacts innovative firms’ voluntary disclosure of product quality information. Our empirical context is the pharmaceutical industry, where firms must decide whether to disclose drug quality information acquired in clinical trials. Leveraging variation in...